Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02124278 · ClinicalTrials.gov registry record · Phase 1
Safety and Tolerability of Single Ascending Doses of PUL-042 Inhalation Solution in Healthy Subjects
A Phase 1 study, sponsored by Pulmotect.
- Completed
- Registry status
- Phase 1
- Development phase
- 42
- Enrollment target
NCT02124278 is a Phase 1 study that has completed, run by Pulmotect. The registered enrollment target is 42 participants.
The verdict
NCT02124278, a Phase 1 study, has completed, sponsored by Pulmotect.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 42 participants
- Enrollment target
Study Summary
The purpose is to determine if single doses of PUL-042 inhalation solution are safe in healthy subjects.
Interventions
- DRUG PUL-042 Inhalation Solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2014-02 |
| Est. Completion | 2014-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02124278
The ClinicalTrials.gov registry entry for NCT02124278 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pulmotect, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PUL-042 Inhalation Solution is the first listed.
NCT02124278 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02124278 about?
NCT02124278 is a clinical study titled "Safety and Tolerability of Single Ascending Doses of PUL-042 Inhalation Solution in Healthy Subjects". The purpose is to determine if single doses of PUL-042 inhalation solution are safe in healthy subjects.
What is the current status of trial NCT02124278?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 42 participants. The study started on 2014-02. Estimated completion is 2014-10.
What interventions are being tested in trial NCT02124278?
The interventions under investigation include: PUL-042 Inhalation Solution (DRUG).
Who is sponsoring clinical trial NCT02124278?
This trial is sponsored by Pulmotect, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.